Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | KLK7 | P49862 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21768461 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL29743149 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL18651139 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL28010837 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL29743150 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL12046593 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL23673200 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL8557040 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL21295799 | 0.97 | TP53 (0.48) | TP53CYP1A2GAACYP2C9PKM | |
| Ammonia Solution, Strong SCHEMBL3684743 | 0.97 | TP53 (0.48) | TP53CYP1A2GAACYP2C9PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113555122-B | Predictive model of transient and persistent AKI of severe sepsis patient and construction method thereof | 中南大学湘雅二医院 | 2024-04-26 | — | — | CN | claimed |
| CN-112125409-B | Method for improving anaerobic denitrification efficiency by coupling oneidensis MR-1 and nano graphene sheet | 同济大学 | 2021-08-20 | — | — | CN | claimed |
| CN-112837826-A | Severe sequential organ failure scoring method and system based on machine learning | 浙江大学温州研究院 | 2021-05-25 | — | — | CN | claimed |
| CN-112125409-A | Method for improving anaerobic denitrification efficiency by coupling oneidensisMR-1 and nano graphene sheet | 同济大学 | 2020-12-25 | — | — | CN | claimed |
| CN-112048500-A | Paracoccus denitrificans/Shewanella/graphene/calcium alginate denitrification gel microsphere as well as preparation method and application thereof | 同济大学 | 2020-12-08 | — | — | CN | claimed |
| EP-2616455-B1 | LACTYLATE SYNTHESIS METHODS USING DILACTIDES | CARAVAN INGREDIENTS INC (US) | 2020-12-02 | — | — | EP | claimed |
| EP-2616455-A1 | LACYLATE SYNTHESIS METHODS USING DILACTIDES | Caravan Ingredients Inc. (US) | 2013-07-24 | — | — | EP | claimed |
| US-8383851-B2 | Lactylate synthesis methods using dilactides | CARAVAN INGREDIENTS INC. (US) | 2013-02-26 | — | — | US | claimed |
| WO-2012036693-A1 | LACYLATE SYNTHESIS METHODS USING DILACTIDES | CARAVAN INGREDIENTS INC. (US) | 2012-03-22 | — | — | WO | claimed |
| US-20120065422-A1 | LACTYLATE SYNTHESIS METHODS USING DILACTIDES | CARAVAN INGREDIENTS INC. (US) | 2012-03-15 | — | — | US | claimed |
| WO-2001072938-A1 | LAUNDRY TREATMENT GRANULE AND DETERGENT COMPOSITION CONTAINING SAME | UNILEVER PLC (GB) | 2001-10-04 | — | — | WO | claimed |
| WO-2001072937-A1 | LAUNDRY TREATMENT FOR FABRICS | UNILEVER PLC (GB) | 2001-10-04 | — | — | WO | claimed |
| WO-2001072944-A1 | LAUNDRY TREATMENT FOR FABRICS | UNILEVER PLC (GB) | 2001-10-04 | — | — | WO | claimed |
| US-6288022-B1 | LAUNDERING FABRIC, I.E., CELLULOSE, IN WASH LIQUOR CONTAINING A WATER SOLUBLE/DISPERSIBLE REBUILD AGENT THAT INCREASES AFFINITY TO FIBER UPON DEESTERIFICATION OF ESTER OR CARBAMATE GROUPS PENDANT TO A POLYMERIC BACKBONE, I.E., CELLULOSE ESTER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-09-11 | — | — | US | claimed |
| EP-1117754-A1 | TREATMENT FOR FABRICS | UNILEVER PLC (GB) | 2001-07-25 | — | — | EP | claimed |
| EP-1117755-A1 | TREATMENT FOR SUBSTRATES | UNILEVER PLC (GB) | 2001-07-25 | — | — | EP | claimed |
| EP-1065144-A1 | Method for packaging mussels and similar shellfish, and thus obtained package with shellfish | Roem van Yerseke B.V. (NL) | 2001-01-03 | — | — | EP | claimed |
| WO-2000018860-A1 | TREATMENT FOR FABRICS | UNILEVER PLC (GB) | 2000-04-06 | — | — | WO | claimed |
| WO-2000018861-A1 | TREATMENT FOR SUBSTRATES | UNILEVER PLC (GB) | 2000-04-06 | — | — | WO | claimed |
| US-5401773-A | Treating comedones | ROUSSEL-UCLAF (FR) | 1995-03-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065422-A1 | LACTYLATE SYNTHESIS METHODS USING DILACTIDES | ELOVL6, LCT, ELOVL1 | TP53 4768/4885CYP1A2 934/4885GAA 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.